Shares of Thermo Fisher Scientific Inc. TMO inched 0.84% higher to $534.42 Tuesday, on what proved to be an all-around mixed ...

Thermo Fisher Scientific Inc., the world leader in serving science, today unveiled the Gibco™ CTS™ Detachable Dynabeads™ CD4 ...

Thermo Fisher Scientific (NYSE:TMO) has completed the repurchase of $1B (1.9M shares) of its common stock. As of Dec. 3, 2024, $3B remained available under the company’s share repurchase authorization ...

Thermo Fisher (TMO) announced that it has completed the repurchase of $1B of its common stock. As of December 3, $3B remained available under ...

Diagnostics is pleased to announce the completion of a €30 million Series D funding round, led by Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science. This investment will ...

Anixa Biosciences, Inc. ("Anixa" or the "Company") , a biotechnology company focused on the treatment and prevention of cancer, announced today that it will be participating in the iAccess Alpha ...

The global synthetic biology market growth forecasted to transform from USD 12.33 billion in 2024 to USD 31.52 billion in 2029, driven by a CAGR of 20.6%. Rising demand for bio-based products, growing ...

Consistent data across subgroups underscore the potential of PrimeC to redefine the standard of care in the treatment of ALS CAMBRIDGE, Mass., Dec. 4, 2024 /PRNewswire/ -- NeuroSense Therapeutics Ltd.

Health care stocks have underperformed in recent months on uncertainty surrounding the incoming Donald Trump administration, but they can often be a solid defensive play in an uncertain economy.

The shooting of UnitedHealthcare CEO Brian Thompson in New York City Wednesday has drawn attention to the protection of top ...

The murder of UnitedHealthcare chief executive Brian Thompson in Manhattan on Wednesday has raised questions about security ...